Takeda's $2.37 billion U.S. drug accord endangered after too few claimants sign up
Takeda Pharmaceutical Co.'s $2.37 billion settlement of thousands of lawsuits over its Actos diabetes medicine did not attract enough takers ahead of a deadline, raising doubts about whether the deal will survive. Asia's largest drugmaker is obligated to fund the deal after 95 percent of ...
Officials at Asia's largest drugmaker have proposed to settle more than 8,000 lawsuits in federal and state courts in the United States, according to sources who asked to remain anonymous.
Takeda told to pay ¥154 million in punitive damages over Actos diabetes drug
A jury ordered Takeda Pharmaceutical Co. to pay ¥154 million ($1.3 million) in punitive damages to a former teacher who argued the drugmaker's Actos diabetes medicine caused his bladder cancer, in the company's fifth loss in trials over the drug. Jurors in state court in ...
U.S. court orders Takeda to pay $6 billion over Actos diabetes drug
Takeda Pharmaceutical Co. said Thursday it has been ordered by a U.S. district court to pay $6 billion in punitive damages over a lawsuit filed by a man who claimed his bladder cancer was caused by Takeda's diabetes medicine Actos. The ruling is in line ...
Pharmaceutical giant Takeda to fight $6 billion damages ruling over hidden cancer risks
Takeda Pharmaceutical Co. says it will contest $6 billion in punitive damages imposed by a jury in the United States in a case that accused Japan’s largest drugmaker of concealing cancer risks associated with its Actos diabetes drug.
U.S. jury orders Takeda to pay $6 billion over Actos diabetes drug
A jury in Louisiana on Monday ordered Takeda Pharmaceutical Co. to pay $6 billion in punitive damages, acknowledging that Japan's largest drugmaker concealed the risks of cancer associated with its diabetes drug Actos, according to Takeda and U.S. media reports. In the case, Terrence Allen, ...
Takeda failed to adequately warn of Actos cancer risks, U.S. jury finds
A Maryland jury has ruled that Takeda Pharmaceutical Co. failed to properly warn a former U.S. Army translator and his doctor about the risks of the firm's Actos diabetes drug and ordered it to pay more than $1.7 million (¥168 million) in damages, but ...
Takeda Pharmaceutical is told to pay $6.5 million to a man who sued Asia's largest drugmaker for failing to warn that its Actos diabetes drug could cause cancer.
Takeda Pharmaceutical is told to pay $6.5 million to a man who sued Asia's largest drugmaker for failing to warn that its Actos diabetes drug could cause cancer.
